BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11939259)

  • 1. Stem cell transplantation for aplastic anemia.
    Georges GE; Storb R
    Int J Hematol; 2002 Feb; 75(2):141-6. PubMed ID: 11939259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
    Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
    Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
    Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
    Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center.
    Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A
    Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for severe aplastic anemia in children.
    Casper JT; Truitt RR; Baxter-Lowe LA; Ash RC
    Am J Pediatr Hematol Oncol; 1990; 12(4):434-48. PubMed ID: 2285124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
    Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
    Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
    Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
    Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
    Horstmann M; Stockschläder M; Krüger W; Hoffknecht M; Betker R; Kabisch H; Zander A
    Ann Hematol; 1995 Aug; 71(2):77-81. PubMed ID: 7654856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.
    Georges GE; Doney K; Storb R
    Blood Adv; 2018 Aug; 2(15):2020-2028. PubMed ID: 30108110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative donor transplantation for aplastic anemia.
    Eapen M; Horowitz MM
    Hematology Am Soc Hematol Educ Program; 2010; 2010():43-6. PubMed ID: 21239769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors.
    Locatelli F; Porta F; Zecca M; Pedrazzoli P; Maccario R; Giani S; Vitale V; Martinetti M; Mazzolari E; Lanfranchi A
    Am J Hematol; 1993 Mar; 42(3):328-33. PubMed ID: 8438907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation for acquired severe aplastic anemia.
    Bacigalupo A
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1145-55. PubMed ID: 25459184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.